Furthermore, GEPIA and ULCAN databases revealed a close association between high expression of SERPINE2 and clinical progression in COAD patients, indicating a correlation between increased levels of SERPINE2 and malignant progression as well as lymph node metastasis(Figure 2C). Here, SERPINE2 is linked to colon adenocarcinoma.